
Shared Decision-Making in Acute Myeloid Leukemia
Caring for patients with acute myeloid leukemia (AML) depends on many factors and can vary as much as the patients themselves. As such, shared decision-making—those collaborative conversations between patient and physician that guide the treatment trajectory—are critical to align goals and help determine what's best for each patient.
Due to the challenges COVID-19 presents for immune-compromised individuals, clinicians are having more complex discussions with their patients diagnosed with AML—including how to proceed with the COVID-19 vaccine and booster shot.
Guests:
Jonathan Abbas, MD…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.